Compare GGG & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GGG | PEN |
|---|---|---|
| Founded | 1926 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Fluid Controls | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.5B | 12.7B |
| IPO Year | 1994 | 2015 |
| Metric | GGG | PEN |
|---|---|---|
| Price | $72.56 | $321.00 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 10 | 17 |
| Target Price | $83.29 | ★ $362.54 |
| AVG Volume (30 Days) | ★ 2.0M | 380.2K |
| Earning Date | 10-21-2026 | 10-29-2026 |
| Dividend Yield | ★ 1.63% | N/A |
| EPS Growth | 9.22 | ★ 1155.56 |
| EPS | 2.32 | ★ 2.77 |
| Revenue | ★ $2,236,604,000.00 | $1,403,665,000.00 |
| Revenue This Year | $4.86 | $14.41 |
| Revenue Next Year | $7.74 | $12.73 |
| P/E Ratio | ★ $31.13 | $115.83 |
| Revenue Growth | 5.83 | ★ 17.50 |
| 52 Week Low | $65.96 | $276.01 |
| 52 Week High | $95.69 | $362.41 |
| Indicator | GGG | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 50.33 | 49.70 |
| Support Level | $66.48 | $315.83 |
| Resistance Level | $77.70 | $325.11 |
| Average True Range (ATR) | 1.67 | 2.65 |
| MACD | 0.65 | -0.14 |
| Stochastic Oscillator | 85.95 | 54.09 |
Graco manufactures equipment used for managing fluids, coatings, and adhesives, specializing in difficult-to-handle materials. Graco's business is organized into three segments: industrial, process, and contractor. The Minnesota-based firm serves a wide range of end markets, including industrial, automotive, and construction, and its broad array of products include pumps, valves, meters, sprayers, and equipment used to apply coatings, sealants, and adhesives. The firm generated roughly $2.2 billion in sales in 2025.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.